CMS suggests eligible professionals participating in the Medicare and Medicaid EHR Incentive Programs not select NQF 0084: Heart Failure: Warfarin Therapy Patients with Atrial Fibrillation as one of their additional clinical quality measures (CQMs) for meaningful use. As there are other FDA-approved medications available for use as an anticoagulant, CMS suggests this measure not be selected as one of the measures reported for the CQM objective.

CMS does not expect eligible professionals to change their certified EHR systems or purchase another system to replace this measure. Eligible professionals may continue to report NQF 0084 for the 2011-2012 program years if their certified EHR system uses a module that is only certified for nine CQMs with this measure included as one of the nine.

To view all 44 clinical quality measure specifications, please download the EP Measure Specifications Zip file.

Additionally, the Guide to Clinical Quality Measures provides an overview of CQMs, how to choose the appropriate CQMs for meaningful use, and how CQMs are reported during attestation.